Growing community of inventors

Medford, MA, United States of America

Ely Blanton Porter

Average Co-Inventor Count = 2.43

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Ely Blanton PorterXi Chen (6 patents)Ely Blanton PorterDarrell J Irvine (2 patents)Ely Blanton PorterRonald Vogels (2 patents)Ely Blanton PorterRon Weiss (2 patents)Ely Blanton PorterMariane Bandeira Melo (2 patents)Ely Blanton PorterTasuku Kitada (2 patents)Ely Blanton PorterMarijn Van Der Neut Kolfschoten (2 patents)Ely Blanton PorterEly Blanton Porter (8 patents)Xi ChenXi Chen (20 patents)Darrell J IrvineDarrell J Irvine (62 patents)Ronald VogelsRonald Vogels (50 patents)Ron WeissRon Weiss (37 patents)Mariane Bandeira MeloMariane Bandeira Melo (5 patents)Tasuku KitadaTasuku Kitada (4 patents)Marijn Van Der Neut KolfschotenMarijn Van Der Neut Kolfschoten (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Rootpath Genomics, Inc. (5 from 5 patents)

2. Massachusetts Institute of Technology (2 from 8,369 patents)

3. Janssen Vaccines & Prevention B.v. (2 from 115 patents)

4. Guangzhou Chengyuan Bioimmunology Technology Co., Ltd. (1 from 1 patent)


8 patents:

1. 12365742 - Compositions and methods for t-cell receptor gene assembly

2. 12116572 - Target binding moiety compositions and methods of use

3. 12098181 - High throughput cloning of paired bipartite immunoreceptor polynucleotides and applications thereof

4. 11964007 - Methods and compositions for heterologous repRNA immunizations

5. 11746162 - Compositions and methods for T-cell receptor gene assembly

6. 11560560 - Target binding moiety compositions and methods of use

7. 11235051 - Methods and compositions for heterologous repRNA immunizations

8. 11208457 - High throughput cloning of paired bipartite immunoreceptor polynucleotides and applications thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…